Binding agreement signed; formal announcement by early next week, pips rival bidders Mankind Pharma-Chrys Cap Healthium is the largest manu...

Oust Labs is a pioneer in micro-learning platforms, having built a proprietary methodology of delivering learning outcomes through its mobi...

India’s startup ecosystem minted two new unicorns this week—one of them the youngest to enter the coveted billion-dollar valuation club. Me...

The company's existing backers March Capital Partners, National Grid Partners, Chiratae Ventures, Iron Pillar Fund and Sistema Capital also...

Satisfying a customer has never been easy. But in today’s fast-changing business scenario, it seems to be a mammoth task Customers have alw...

Constellation was formed as a public platform for acquiring Indian healthcare businesses. Constellation raised $144 million in its initial ...

Vamsi was the Founder of 'Inferatics Consulting Labs', a product management firm consulting startups in ideation phase, validating products...

With cyber criminals keeping tabs on the social media footprint of the well-heeled, you may be at risk of virtual extortion.

Vishy Chebrol, one of the founders and managing directors of InvAscent, confirmed the fund is looking at exiting its investment in the comp...

Dr Lal PathLabs has mandated investment banks Kotak Investment Bank and Citi Investment Bank to lead its initial public offering.

Hopes of some high value launches over the next few months have also boosted sentiment in the stock. It has risen as much as 60% so far in ...

Dr Lal PathLabs is undertaking a restructuring exercise to determine the issue size of its potential IPO and a decision is expected by Dece...

The oversubscription of India Life Sciences Fund II shows that investors are open to funds offering focused expertise in certain key indust...

Commenting on valuation, Velumani said, the market will decide the valuation, which is likely to be between Rs 1,800 crore and Rs 2,200 cro...

Aditya Birla PE is close to acquiring a stake in Thyrocare as financial investors build up interest in the domestic diagnostic services sec...

Research at IBM today is about collaborating with sales people and customers to develop relevant products, said a top scientist at the comp...

Velumani, son of a landless farmer, hopes his co will notch up revenues of Rs 150-160 crore this financial year on the back of expansion.